Ligand bias underlies differential signaling of multiple FGFs via FGFR1

• DOI: 10.7554/elife.88144.3
• Publication Date: 2023-10-16T22:05:50Z
• Authors: Kelly Karl; Nuala Del Piccolo; Taylor Light; Tanaya Roy; Pooja Dudeja; Vlad-Constantin U...; Bohumil Fafilek; Pavel Krejci; Kalina Hristova
• Keywords: 0301 basic medicine; FGFR; QH301-705.5; Science; Structural Biology and Molecular Biophysics; Q; R; Ligands; Fibroblast Growth Factors; signal transduction; FGFR; biased signaling; None; 03 medical and health sciences; Bias; Pregnancy; Medicine; Humans; Female; Receptor, Fibroblast Growth Factor, Type 1; Biology (General); Phosphorylation; signal transduction; biased signaling; Signal Transduction

Abstract The mechanism of differential signaling of multiple FGF ligands through a single FGF receptor is poorly understood. Here, we use biophysical tools to quantify multiple aspects of FGFR1 signaling in response to FGF4, FGF8 and FGF9: potency, efficacy, bias, ligand-induced oligomerization and downregulation, and conformation of the active FGFR1 dimers. We find that the three ligands exhibit distinctly different potencies and efficacies for inducing responses in cells. We further discover qualitative differences in the actions of the three FGFs through FGFR1, as FGF8 preferentially activates some of the probed downstream responses (FRS2 phosphorylation and extracellular matrix loss), while FGF4 and FGF9 preferentially activate different probed responses (FGFR1 phosphorylation and cell growth arrest). Thus, FGF8 is a biased ligand, when compared to FGF4 and FGF9. Förster resonance energy transfer experiments reveal a correlation between biased signaling and the conformation of the FGFR1 transmembrane domain dimer. Our findings expand the mechanistic understanding of FGF signaling during development and bring the poorly understood concept of receptor tyrosine kinase ligand bias into the spotlight.